FDA accepts Cornerstone’s metabolic disorder drug application
(Reuters) – Cornerstone Therapeutics said U.S. health regulators have accepted the specialty pharmaceutical company's marketing application for its drug to treat low blood sodium levels. The U.S. Food and Drug Administration has set an action …
View full post on Yahoo! Health News
accepts, application, Cornerstone's, Disorder, drug, Metabolic
